KemPharm (KMPH) Misses Q3 EPS by 26c
Tweet
Share
E-mailKemPharm (NASDAQ: KMPH) reported Q3 EPS of ($0.68), $0.26 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on KemPharm (KMPH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nike (NKE) Tops Q1 EPS by 4c
- Barclays Upgrades Universal Music Group NV (UMG:NA) (UMGNF) to Overweight
- Roth/MKM Starts Suja Life Inc. (SUJA) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
